• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pulmonary Edema (2020)
Event Type  Injury  
Manufacturer Narrative
Unknown since the batch/lot number was not provided.(b)(4).The results of the investigation are inconclusive since the device was not returned for analysis.A review of the device history record was not possible since the serial number was unavailable.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The information comes from the abstract titled "comparison of clinical outcomes after transcatheter vs.Minimally invasive cardiac surgery closure for atrial septal defect" from the "circulation journal" vol.81, no.4, 2017.Page 543-551.Summary: the success rate was 98% for the percutaneous group and 100% for the mics (minimally invasive cardiac surgery) group.A comparison between these two groups showed no significant differences.Minor complications in the mics group have a significantly higher incidence rate than in the percutaneous group.This study showed that percutaneous closure of atrial septal defect (asd) can be considered as the first therapeutic option for the patient with a suitable anatomy whereas there are anatomical limitations.In this single-center retrospective study between 2000 and 2013, percutaneous asd closure using amplatzer septal occluder (aso) was conducted in 134 patients between 2011 and 2013.There were adverse events after the procedure in 2 patients reported: this case of pulmonary edema requiring intravenous diuretics as major complications (per (b)(4)) and another case of anemia requiring blood transfusion as minor complications (per (b)(4)).No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key6629761
MDR Text Key77233798
Report Number2135147-2017-00064
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/16/2017
Initial Date FDA Received06/09/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-